DF Dent & Co. Inc. Trims Holdings in Trupanion, Inc. (NASDAQ:TRUP)

DF Dent & Co. Inc. trimmed its holdings in Trupanion, Inc. (NASDAQ:TRUP) by 3.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 353,434 shares of the financial services provider’s stock after selling 14,437 shares during the quarter. DF Dent & Co. Inc. owned about 0.83% of Trupanion worth $17,036,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently bought and sold shares of the company. SBI Securities Co. Ltd. purchased a new position in shares of Trupanion in the 4th quarter worth about $25,000. Jones Financial Companies Lllp raised its holdings in Trupanion by 71.7% in the fourth quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider’s stock worth $27,000 after buying an additional 238 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new position in shares of Trupanion in the third quarter worth approximately $54,000. KBC Group NV bought a new position in shares of Trupanion in the fourth quarter worth approximately $75,000. Finally, R Squared Ltd purchased a new stake in shares of Trupanion during the fourth quarter valued at approximately $79,000.

Trupanion Stock Performance

Shares of TRUP opened at $37.26 on Thursday. Trupanion, Inc. has a one year low of $19.69 and a one year high of $57.90. The business has a fifty day moving average of $40.20 and a 200 day moving average of $46.36. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. The firm has a market capitalization of $1.58 billion, a P/E ratio of -162.00, a PEG ratio of 6.02 and a beta of 1.70.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The firm had revenue of $337.31 million for the quarter, compared to the consensus estimate of $335.41 million. As a group, sell-side analysts anticipate that Trupanion, Inc. will post 0.13 EPS for the current year.

Insiders Place Their Bets

In related news, CFO Fawwad Qureshi sold 1,373 shares of the business’s stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total transaction of $46,984.06. Following the completion of the transaction, the chief financial officer now directly owns 2,416 shares in the company, valued at approximately $82,675.52. The trade was a 36.24 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Margaret Tooth sold 4,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $37.17, for a total transaction of $148,680.00. Following the sale, the chief executive officer now owns 118,784 shares in the company, valued at approximately $4,415,201.28. The trade was a 3.26 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 29,984 shares of company stock worth $999,042. Company insiders own 5.50% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Piper Sandler decreased their price objective on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a report on Thursday, February 20th. Stifel Nicolaus decreased their price target on Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a research note on Thursday, February 20th. Two analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $46.60.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.